Perioperative empagliflozin and risk of acute kidney injury after cardiac surgery: a systematic review and meta-analysis
Hypertension is the leading modifiable risk factor for cardiovascular disease globally, driven by a sodium-rich, potassium-poor dietary phenotype. Whilst potassium-enriched salt substitutes (PESS) demonstrate hypotensive potential, widespread clinical implementation is hindered by theoretical concerns regarding f...